콘텐츠로 건너뛰기
주식/증권 📈 긍정적

Johnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble. Stock Falls.

요약

Johnson & Johnson says it is working to improve results in its medical-device business, where surgery revenue fell for the latest quarter.